Recipharm Appoints New Position of Vice President Quality Management
News Mar 11, 2015
Recipharm has announced that it has appointed Thomas Beck to the new senior role of Vice President Quality Management (VP QM) with effect from 1st April 2015. Thomas is currently Head of Quality Control and Assurance at Recipharm Stockholm, a position that he has held since 2010. He is also Chairman of the Quality Assurance section within the Swedish Academy of Pharmaceutical Science.
In this new role Thomas will drive and coordinate the quality strategy and policy across the Recipharm Group subsidiaries and assist the Group Management Team (GMT) in monitoring and evaluating the company’s quality efforts. He will also lead the company’s audit process and support the sales activity by providing a primary contact point for new customers’ regulatory and quality affairs departments.
Reporting to the EVP Chief Operation Officer (COO) this post, represents an expansion of the Group Management Team (GMT) in a move designed to help it meet the increased demands the Group is facing following the recent rapid growth.
Commenting on the new appointment, Thomas Eldered, CEO of Recipharm, remarked: “This new position will bolster and enhance the work of the Group Management Team, meeting head on the quality management challenges our industry faces. Thomas will take a pivotal role in ensuring that we deliver and practice the highest standards of quality right across the entire Recipharm Group. He personally brings strong quality management expertise and already has specific experience of operations at Recipharm and the high standards that we are committed to delivering for our customers. I very much look forward to his authoritative support and direction being brought to bear for the benefit of the Group as a whole.”
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018